Modern methods of therapy of Duchenne muscular dystrophy: literature review with a clinical case
Duchenne muscular dystrophy is a genetic, X-linked, relentlessly progressive disease. Due to a genetic defect, the reading frame is disrupted during the synthesis of the dystrophin protein, resulting in its loss of functionality. As a result of the absence of dystrophin, there is a gradual destructi...
Saved in:
| Main Authors: | S. B. Artemyeva, О. А. Shidlovskaya, Yu. О. Papina, А. V. Monakhova, I. V. Shulyakov, D. V. Vlodavets |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2024-01-01
|
| Series: | Нервно-мышечные болезни |
| Subjects: | |
| Online Access: | https://nmb.abvpress.ru/jour/article/view/578 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of Viltepso® in Duchenne muscular dystrophy: review of clinical studies
by: V. M. Suslov, et al.
Published: (2024-11-01) -
Advances in Nucleic Acid Drugs and Gene Therapies based on Animal Models of Duchenne Muscular Dystrophy
by: LIU Siyu, et al.
Published: (2024-12-01) -
Possibility of exon skipping therapy for Duchenne muscular dystrophy in Russian patients: present and future
by: E. V. Zinina, et al.
Published: (2024-09-01) -
Understanding Duchenne muscular dystrophy-associated brain pathology
by: Minou A. T. Verhaeg, et al.
Published: (2025-07-01) -
Experience of observing patients with Duchenne myopathy
by: L. I. Minaycheva, et al.
Published: (2023-12-01)